Augustina Isioma Ikusemoro/LinkedIn
Apr 2, 2026, 04:47
Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Know Your Kell: A Small Antigen with Big Clinical Consequences
The Kell antigen system is one of the most clinically significant blood group systems after ABO and Rh, yet it is often under-recognized outside specialist transfusion practice.
This infographic highlights why the K antigen (K1) matters in everyday transfusion medicine:
- The Kell antigen is expressed on red blood cells and can trigger clinically significant alloimmunization
- Anti-K antibodies are a major cause of Hemolytic Disease of the Fetus and Newborn (HDFN)
- Sensitization commonly occurs after transfusion or pregnancy
- Anti-K is typically IgG reactive at 37°C, capable of crossing the placenta
- Safe transfusion practice requires Kell-negative blood for patients with anti-K antibodies
Understanding Kell compatibility is essential for protecting:
- chronically transfused patients
- women of child-bearing age
- fetuses at risk of HDFN
- patients with previous alloimmunization
Because in transfusion medicine, compatibility goes far beyond ABO and RhD.
Blood Doki — Advancing transfusion safety through education, advocacy, and clinical awareness.”
Stay updated with Hemostasis Today.
-
Apr 2, 2026, 04:28Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
-
Apr 2, 2026, 04:18Emmanuele Kouvousis: Physical Inactivity as a Leading Global Health Risk
-
Apr 2, 2026, 04:03Robert Lufkin: The Misleading Concept of Metabolically Healthy Obesity in Childhood
-
Apr 1, 2026, 23:00Wolfgang Miesbach: What Goes Wrong When Approved Gene Therapies Get Withdrawn?
-
Apr 1, 2026, 22:00Aurelio Maggio: Congratulations to Mariasanta Napolitano on Her 1st Year Leading the Haematology and Rare Disease Uni tat ”V. Cervello” Hospital
-
Apr 1, 2026, 21:21Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
-
Apr 1, 2026, 21:00Johns Hopkins All Children’s Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence – NBCA
-
Apr 1, 2026, 20:17Aswin K Mohan: The Most Common Misconceptions on Blood Donation
-
Apr 1, 2026, 19:26Thomas Vogl: Simon Bernatz Demonstrates that The Thymus Plays a Crucial Role in Health, Immune Resilience, and Longevity